A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy
- PMID: 33907419
- PMCID: PMC8068480
- DOI: 10.2147/OTT.S260391
A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy
Abstract
The properties of cancer stem cells (CSCs) have recently gained attention as an avenue of intervention for cancer therapy. In this review, we highlight some of the key roles of CSCs in altering the cellular microenvironment in favor of cancer progression. We also report on various studies in this field which focus on transformative properties of CSCs and their influence on surrounding cells or targets through the release of cellular cargo in the form of extracellular vesicles. The findings from these studies encourage the development of novel interventional therapies that can target and prevent cancer through efficient, more effective methods. These methods include targeting immunosuppressive proteins and biomarkers, promoting immunization against tumors, exosome-mediated CSC conversion, and a focus on the quiescent properties of CSCs and their role in cancer progression. The resulting therapeutic benefit and transformative potential of these novel approaches to stem cell-based cancer therapy provide a new direction in cancer treatment, which can focus on nanoscale, molecular properties of the cellular microenvironment and establish a more precision medicine-oriented paradigm of treatment.
Keywords: biomarkers; cancer; exosomes; molecular imaging; stem cell therapy.
© 2021 Hayat et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures

Similar articles
-
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.Cancer Cell Int. 2024 Oct 5;24(1):334. doi: 10.1186/s12935-024-03514-y. Cancer Cell Int. 2024. PMID: 39369258 Free PMC article. Review.
-
Exosomes and Cancer Stem Cells in Cancer Immunity: Current Reports and Future Directions.Vaccines (Basel). 2021 May 1;9(5):441. doi: 10.3390/vaccines9050441. Vaccines (Basel). 2021. PMID: 34062950 Free PMC article. Review.
-
Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.J Biochem Mol Toxicol. 2024 Jun;38(6):e23719. doi: 10.1002/jbt.23719. J Biochem Mol Toxicol. 2024. PMID: 38764138 Review.
-
Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.ACS Biomater Sci Eng. 2022 Nov 14;8(11):4673-4696. doi: 10.1021/acsbiomaterials.2c00484. Epub 2022 Oct 4. ACS Biomater Sci Eng. 2022. PMID: 36194142 Review.
-
Stem cell programs in cancer initiation, progression, and therapy resistance.Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020. Theranostics. 2020. PMID: 32754274 Free PMC article. Review.
Cited by
-
Li-Doped Bioactive Ceramics: Promising Biomaterials for Tissue Engineering and Regenerative Medicine.J Funct Biomater. 2022 Sep 24;13(4):162. doi: 10.3390/jfb13040162. J Funct Biomater. 2022. PMID: 36278631 Free PMC article. Review.
-
The Impact of Cancer Stem Cells in Colorectal Cancer.Int J Mol Sci. 2024 Apr 9;25(8):4140. doi: 10.3390/ijms25084140. Int J Mol Sci. 2024. PMID: 38673727 Free PMC article. Review.
-
Cellular activation pathways and interaction networks in vascularized composite allotransplantation.Front Immunol. 2023 May 17;14:1179355. doi: 10.3389/fimmu.2023.1179355. eCollection 2023. Front Immunol. 2023. PMID: 37266446 Free PMC article. Review.
-
Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development.Int J Mol Sci. 2022 Jan 6;23(2):625. doi: 10.3390/ijms23020625. Int J Mol Sci. 2022. PMID: 35054811 Free PMC article. Review.
-
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0. Mol Cancer. 2023. PMID: 38017433 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources